Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
March 18, 2026
PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected PacBio HiFi sequencing on the Revio® system [...]
March 18, 2026
Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit • NIH-funded project leverages collaborators’ expertise in single-molecule proteomics and protein isoform quantification to advance high-resolution cancer isoform analysis SEATTLE -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced Baylor [...]
March 18, 2026
Software enhancements strengthen compliance support with better traceability, audit readiness, and operational efficiency SANTA CLARA, Calif. -- Picarro Inc., a global leader in high-precision gas concentration analytical solutions, today announced the launch of the PI2124 Analyzer, an advanced solution for vaporized hydrogen peroxide (VHP) monitoring in pharmaceutical and other regulated manufacturing environments. The new analyzer continuously measures [...]
March 18, 2026
Roche’s Ionify® steroid assays join its Vitamin D Total test as the latest mass spectrometry tests to receive CLIA ‘moderate complexity’ classification. The expanded steroid menu brings the sensitivity and specificity of mass spectrometry – the diagnostic gold standard – into routine clinical laboratories. The CLIA classification broadens access to advanced testing through a fully [...]
March 18, 2026
IPSWICH, Mass. -- New England Biolabs (NEB®) today announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in collaboration with Touchlight. This novel kit enables the benchtop enzymatic synthesis of Touchlight's proprietary doggybone™ DNA (dbDNA), a linear, covalently closed, double-stranded DNA, providing researchers with a rapid, cell-free alternative to traditional plasmid DNA for the development of [...]
March 18, 2026
Sai Life Sciences' Boston site designated as co-marketed U.S. execution hub for Mabtech's EYRA platform, bringing high-sensitivity multiplex immune profiling to biopharma and biotech clients across the United States STOCKHOLM and BOSTON -- Mabtech, a Swedish life science tools company specializing in high-quality immunoassays, reagents, and instrumentation, today announced a strategic collaboration with Sai Life Sciences, a leading [...]
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
March 18, 2026
The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally. By partnering with Anthropic, Ultima Genomics, and PacBio, and powered by NVIDIA AI infrastructure, Basecamp Research aims to compress over two decades of biological data gathering and analysis into less [...]
Refeyn launches MyMass instrument to simplify sample quality assessment for structural biology
March 18, 2026
Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experiments OXFORD, United Kingdom -- Refeyn, developer of pioneering mass photometry technology, announces the launch of MyMass™ mass photometer (MyMassMP), a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis? [...]
March 18, 2026
World First: Quintessence Biotech reinvents bio-separation to remove the manufacturing bottleneck that has kept cell and gene therapy available to only 1% of eligible patients. CGT can finally become a standard of care. Up to 60% reduction in cost of goods (COGS) through radical process simplification 12× more therapeutic doses produced per site Doubling therapeutic [...]
March 18, 2026
Collaboration deploys the High Throughput In Situ Multiomics capabilities of G4X™ to support HTAN's Pre-Gastric Cancer program and enable scalable generation of multimodal 3D atlases. SAN DIEGO and NASHVILLE, Tenn. -- Singular Genomics today announced a collaboration with Vanderbilt University Medical Center (VUMC) to establish a Center of Excellence leveraging the G4X™ Spatial Sequencer in support of the Human Tumor Atlas Network (HTAN) Pre-Gastric Cancer program. [...]

